Polen Capital Repligen Corp Transaction History

Polen Capital Management LLC

  • $30.8 Billion
  • Q3 2025

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
SELL
$108.89 - $145.23 $3.16 Million - $4.21 Million
-28,985 Reduced 93.8%
1,917 $238,000
Q1 2025

May 12, 2025
SELL
$127.24 - $174.24 $1.23 Million - $1.68 Million
-9,654 Reduced 23.8%
30,902 $3.93 Million
Q4 2024

Feb 10, 2025
BUY
$123.41 - $160.92 $638,399 - $832,439
5,173 Added 14.62%
40,556 $5.84 Million
Q3 2024

Nov 13, 2024
BUY
$119.79 - $167.35 $2.49 Million - $3.48 Million
20,811 Added 142.81%
35,383 $5.27 Million
Q2 2024

Aug 12, 2024
BUY
$120.0 - $182.95 $1.75 Million - $2.67 Million
14,572 New
14,572 $1.84 Million

Others Institutions Holding RGEN

# of Institutions
523
Shares Held
58.7M
Call Options Held
321K
Put Options Held
667K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.46B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track Polen Capital's Portfolio

Track Polen Capital Portfolio

Follow Polen Capital (Polen Capital Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polen Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Polen Capital Management LLC and Polen Capital with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email